CLSD - Clearside Biomedical to Host Virtual Key Opinion Leader Event on the Use and Versatility of Suprachoroidal Drug Delivery | Benzinga
- Webinar to be held on Wednesday, July 24, 2024 at 8:00 am ET -
- Retina Specialists to Provide Insights and Real-World Experience with Suprachoroidal Drug Delivery -
- Target Profile for CLS-AX in Wet AMD Landscape and Potential Opportunities for Clearside Pipeline Expansion -
ALPHARETTA, Ga., June 27, 2024 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS®), announced plans to host a virtual key opinion leader (KOL) event on Wednesday, July 24, 2024 from 8:00 - 9:15 am ET.
The event will highlight the broad applicability and real-world experience with suprachoroidal drug delivery, the SCS as a differentiator in the retinal treatment landscape with a focus on neovascular age-related macular degeneration (wet AMD), and ongoing SCS clinical programs, including potential future development opportunities for Clearside.
The event will include presentations by the following retinal experts concluding with a live question-and-answer session with the KOLs and Clearside senior management:
- David M. Brown, M.D., Director of Research, Retina Consultants Houston
- Glenn C. Yiu, M.D., Ph.D., Professor of Ophthalmology, University of California, Davis
- Victor Chong, M.D., MBA, Chief Medical Officer, Clearside Biomedical
The live and archived webcast will be accessible on the Clearside website under the Investors section: Events and Presentations.
Biographies of Retinal Specialists
David M. Brown, M.D., Director of Research at Retina Consultants Houston, is a medical and surgical retinal specialist and clinical trial specialist. He has pioneered research in the areas of age-related macular degeneration (AMD), diabetic retinopathy, and retinal vein occlusion. He is the director of the Greater Houston Retina Research Center, a clinical professor of Ophthalmology at Baylor College of Medicine, the Vice-Chair for research at the Blanton Eye Institute at Houston Methodist Hospital and serves as the consultant retinal specialist for NASA. Dr. Brown received his medical degree from Baylor College of Medicine and ...